(Q38003199)

26 August 2017

title

The clinical management of bipolar disorder complexity using a stratified model (English)

1 reference

26 August 2017

1 reference

1

Gin S Malhi

1 reference

26 August 2017

4

Mark A Frye

1 reference

26 August 2017

Danielle M Bargh

2

1 reference

26 August 2017

Emma Cashman

series ordinal

3

1 reference

26 August 2017

Michael Gitlin

series ordinal

5

1 reference

26 August 2017

publication date

1 May 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

14 Suppl 2

1 reference

26 August 2017

page(s)

66-89

1 reference

Rapid-cycling bipolar disorder: cross-national community study

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Early stages in the development of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Perceptions and Impact of Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Clinical practice recommendations for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Psychosocial Disability in the Course of Bipolar I and II Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Meta-analytic review of neurocognition in bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Pharmacotherapy for the treatment of acute bipolar II depression: current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A prospective study of the transition rates of subthreshold (hypo)mania and depression in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Bipolar II disorder: personality and outcome in two clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Progression along the bipolar spectrum: a longitudinal study of predictors of conversion from bipolar spectrum conditions to bipolar I and II disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Divalproex extended-release in acute bipolar II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Psychotherapy as monotherapy for the treatment of bipolar II depression: a proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Hypomania: hype or mania?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Subsyndromal symptoms assessed in longitudinal, prospective follow‐up of a cohort of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Towards a reconceptualization of mixed states, based on an emotional-reactivity dimensional model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Secular trends in first hospitalizations for major mood disorders with comorbid substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Differences in incidence of suicide attempts during phases of bipolar I and II disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Efficacy of antimanic treatments in mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Severity of affective temperament and maladaptive self-schemas differentiate borderline patients, bipolar patients, and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The long-term course of rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Suicide risk in rapid cycling bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Creativity and mental disorder: family study of 300,000 people with severe mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Great wits and madness: more near allied?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Borderline personality disorder and the misdiagnosis of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A comparison of depressed patients with and without borderline personality disorder: implications for interpreting studies of the validity of the bipolar spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: a 3-month randomised controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The effectiveness of dialectical behaviour therapy in routine public mental health settings: An Australian controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Do improvements after inpatient dialectial behavioral therapy persist in the long term? A naturalistic follow-up in patients with borderline personality disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lifetime co-morbidity with different subtypes of eating disorders in 148 females with bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Prevalence and correlates of eating disorders in 875 patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Frequency of comorbid personality disorders in bipolar and unipolar affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Personality disorder comorbidity among patients with bipolar I disorder in remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Medical comorbidity in women and men with bipolar disorders: a population-based controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Anxiety disorder comobidity in Bipolar I Disorder: relationship to depression severity and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Psychopathological correlates of lifetime anxiety comorbidity in bipolar I patients: findings from a French national cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Psychotherapies for comorbid anxiety in bipolar spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Divalproex in the treatment of bipolar depression: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Adjunctive gabapentin treatment of bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The impact of substance abuse on the course of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Substance use disorders and suicide attempts in bipolar subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Suicide risk in bipolar patients: the role of co-morbid substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Treatment delay and excessive substance use in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

New medication strategies for comorbid substance use and bipolar affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Divalproex loading in the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Effects of lamotrigine in patients with bipolar disorder and alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Prevalence of diabetes in patients with bipolar disorder in Taiwan: a population-based national health insurance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

National trends in the outpatient diagnosis and treatment of bipolar disorder in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Pediatric bipolar disorder in a Spanish sample: features before and at the time of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Prepubertal bipolar disorder: proper diagnosis should lead to better treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Psychopharmacology of pediatric bipolar disorders in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Preventative strategies for early-onset bipolar disorder: towards a clinical staging model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Olanzapine versus placebo in the treatment of adolescents with bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Open-label lithium for the treatment of adolescents with bipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

An open-label study of aripiprazole in children with a bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Geriatric bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Differences in clinical features and mental health service use in bipolar disorder across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lithium for older adults with bipolar disorder: Should it still be considered a first-line agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A pilot study of standardized treatment in geriatric bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Suicide risk in patients treated with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Lithium treatment and risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Divalproex treatment of mania in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Evidence-based pharmacological treatment of geriatric bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Quetiapine for the treatment of bipolar mania in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Longitudinal assessment of psychotherapeutic day hospital treatment for elderly patients with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Management of bipolar disorder during pregnancy and the postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Protective effect of pregnancy in women with lithium-responsive bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A reevaluation of risk of in utero exposure to lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Neurodevelopmental effects of prenatal exposure to psychotropic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Olanzapine-exposed pregnancies and lactation: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

The International Lamotrigine pregnancy registry update for the epilepsy foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

ECT in pregnancy: a review of the literature from 1941 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Episodes of mood disorders in 2,252 pregnancies and postpartum periods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Assessment and treatment of bipolar II postpartum depression: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Treatment-resistant bipolar depression: towards a new definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Effects of stimulus intensity on the efficacy and safety of twice-weekly, bilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Bipolar depression: pharmacotherapy and related therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Non-pharmacological treatments in the management of rapid cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Use of topiramate in treatment-resistant bipolar spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

A pilot study of topiramate as monotherapy in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Effect of comorbid anxiety on treatment response in bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Clozapine and lorazepam administration in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Quetiapine dosage in bipolar disorder episodes and mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

Experience with the Atypical Antipsychotics - Risperidone and Olanzapine in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00993.X

10.1111/J.1399-5618.2012.00993.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference